Glycemic control and coagulation inhibitors in diabetic patients

Haemostasis

Volumn 28, Issue 6, 1998, Pages 307-312

  Altunbaş, Hasan ^a   Karayalçin, Ümit ^a   Ündar, Levent ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Antithrombin III; Diabetes mellitus; Heparin cofactor II; Protein C; Protein S

Indexed keywords

ANTIDIABETIC AGENT; ANTITHROMBIN III; BINDING PROTEIN; BLOOD CLOTTING INHIBITOR; COMPLEMENT COMPONENT C4B; GLUCOSE; HEMOGLOBIN A1C; HEPARIN COFACTOR II; INSULIN; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEPHELOMETRY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032321943     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022447     Document Type: Article

References (42)

1. Schafer AI: The hypercoagulable states. Ann Intern Med 1985;102:814-828.
2. Ostermann H, van de Loo J: Factors of the hemostatic system in diabetic patients. Haemostasis 1986;16:386-416.
3. Kwaan HC: Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes 1992;41(suppl 2):32-35.
4. Ceriello A: Coagulation activation in diabetes mellitus: The role of hyperglycaemia in therapeutic prospects. Diabetologia 1993;36:1119-1125.
5. Colwell JA: Vascular thrombosis in type II diabetes mellitus. Diabetes 1993;42:8-11.
6. Grant MB, Fitzgerald C, Guay C, Lottenberg R: Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitus. Metabolism 1989;38:901-907.
7. van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR: Glycometabolic control and fibrinolysis in diabetic patients. Haemostasis 1990;20:241-250.
8. Schneider DJ, Nordt TK, Sobel BE: Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1-7.
9. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE: Factors responsible for impaired fibrinolysis in obese subjects and NIDDM. Diabetes 1994;43:104-109.
10. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Torella R: Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988;31:889-891.
11. Ganda OM, Arkin CF: Hyperfibrinogenemia - An important risk factor for vascular complications in diabetes. Diabetes Care 1992;15:1245-1250.
12. Ishibashi T, Tanaka K, Taniguchi Y: Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 1981;30:601-606.
13. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Cries FA: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991;17:433-438.
14. Classman AB: Platelet abnormalities in diabetes mellitus. Ann Clin Lab Sci 1993;23:47-50.
15. Juhan I, Buonocore M, Jouve R, Vague P, Moulin JP, Vialettes B: Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1982;i:535-537.
16. Tschoepe D, Roesen P, Schwippert B, Cries F: Platelets in diabetes: The role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 1993;19:122-128.
17. Koert M, Nowak-Göttl U, Kreuz W, Grüttner HP, Kornhuber B, Breddin K: 15 parameters of coagulation and fibrinolysis in children with type 1 diabetes mellitus (onset period). Klin Pädiatr 1995;203:429-432.
18. Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R: Haemostatic variables associated with diabetes and its complications. Br Med J 1979;ii:964-966.
19. Christe M, Fritschi J, Lammle B, Tran TH, Marbel GA, Berger W, Duckert F: Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemost 1984;52:138-143.
20. Ceriello A, Dello Russo P, Zuccotti C, Florio A, Nazzaro S, Pietrantuono C, Rosato GB: Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation - A preliminary report. Thromb Haemost 1983;50:633-644.
21. Schernthaner G, Vukovich T, Knöbl P, Hay U, Müller M: The effect of near-normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin-dependent diabetic patients. Br J Haematol 1989;73:356-359.
22. Saito M, Kumabashiri I, Jokaji H, Asakura H, Uotani C, Otsuka M, Hamada M, Tatsumuro M, Morigana K, Matsuda T: The levels of protein C and protein S in plasma in patients with type II diabetes mellitus. Thromb Res 1988;52:479-486.
23. Schwarz HP, Schernthaner G, Griffin JH: Decreased plasma levels of protein S in well-controlled type I diabetes mellitus, Thromb Haemost 1987;57/2:240.
24. Vukovich T, Schernthaner G: Decreased protein C levels in patient with insulin dependent type 1 diabetes mellitus. Diabetes 1986;35:617-619.
25. Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R, Vukovich T: Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 1984;71:692-698.
26. Blavy G, N'Guessan R: Antithrombin III activity and diabetes mellitus in the Ivory Coast population. Nouv Rev Fr Hematol 1992;34:315-316.
27. Bick RL: Clinical relevance of antithrombin III. Semin Thromb Hemost 1982;8:276-287.
28. Briginshaw GF, Shanberge JN: Identification of two distinct heparin cofactors in human plasma. Separation and partial purification. Arch Biochem Biophys 1974;61:683-690.
29. Clouse LH, Comp PC: The regulation of hemostasis: The protein C system. N Engl J Med 1986;314:1298-1303.
30. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefebvre P: Evidence for a hyperglycaemiadependent decrease of antithrombin III-thrombin complex formation in humans. Diabetologia 1990;33:163-167.
31. Ceriello A, Giugliano D, Quatraro A, Consoli G, Stante A, Dello Russo P, D'Onofrio F: Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 1987;36:320-323.
32. Duboscq C, Quintana I, Barros J, Kordich L: Heparin cofactor II in diabetic patients. Blood Coagul Fibrinolysis 1994;5/2:201-214.
33. Ceriello A, Quatraro A, Dello Russo P, Marchi E, Milani MR, Giugliano D: Evidence for a reduced heparin cofactor II biological activity in diabetes. Haemostasis 1990;20:357-361.
34. Ceriello A, Marchi E, Barbanti M, Milani MR, Giugliano D, Quatraro A, Lefebvre P: Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. Diabetologia 1990;33:205-207.
35. El Khawand C, Jamart J, Donckier J, Chatelain B, Lavenne E, Moriau M, Buysschaert M: Hemostasis variables in type 1 diabetic patients without demonstrable vascular complications. Diabetes Care 1993;16:1137-1145.
36. Vigano S, Manucci P, D'Angelo A, Gelfi C, Gensini GF, Rostagno C, Neri Serneri GG: Protein C antigen is not acute phase reactant and is often high in ischemic heart disease and diabetes. Thromb Haemost 1984;52:263-266.
37. Ceriello A, Quatraro A, Dello Russo P, Marchi E, Barbanti M, Milani NMR, Giugliano D: Protein C deficiency in insulin-dependent diabetes: A hyperglycemia-related phenomenon. Thromb Haemost 1990;64/1:104-107.
38. Ündar L, Karadoǧan I, Akça S, Ertuǧrul C, Altunbaş H: Circadian variation in natural coagulation inhibitors protein C, protein S and antithrombin-III in healthy men (abstract). Br J Haematol 1996;93(suppl 2):6.
39. Villanueva GB, Allen N: Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients. Diabetes 1988;37:1103-1107.
40. Ceriello A, Curcio F, Dello Russo P, Giugliano D: Non-enzymatic glycosylation reduces antithrombin III activity (letter). Thromb Haemost 1984;52:363.
41. Conlan MG, Folsom AR, Finch A, Davis CE, Marcucci G, Sorlie P, Wu KK: Antithrombin III: Associations with age, race, sex, and cardiovascular disease risk factors. Thromb Haemost 1994;72:551-556.
42. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefebvre P: Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type 1 diabetes. Diabetes 1990;39:447-449.